Loading data
SEVNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Research and development expense | 21.34 m USD | 17.03 m USD | 23.67 m USD |
| Selling, general and administrative expense | 26.77 m USD | 20.09 m USD | 37.48 m USD |
| Operating profit | -48.11 m USD | -37.12 m USD | -61.14 m USD |
| Net income (reported basis) | -43.91 m USD | -34.91 m USD | -59.29 m USD |
| Basic earnings per share | -1.79 USD/share | -1.52 USD/share | — |
| Diluted earnings per share | -1.79 USD/share | -1.52 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.